Subtyping for pancreatic cancer precision therapy

Trends in Pharmacological Sciences - Tập 43 - Trang 482-494 - 2022
Xing Huang1,2,3,4,5, Gang Zhang1,2,3,4,5, Tingbo Liang1,2,3,4,5
1Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, Zhejiang, China
2Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China
3Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Diseases, Hangzhou 310003, Zhejiang, China
4The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Hangzhou 310009, Zhejiang, China
5Cancer Center, Zhejiang University, Hangzhou 310058, Zhejiang, China.